1. Adams, A., Strander, H., Cantell, K.: Sensitivity of the Epstein-Barr virus transformed human lymphoid cell lines to interferon. J. gen. Virol.28, 207?217 (1975).
2. Borecky, L., Lackovi?, V. V., Fuchsberger, N., Hajnická-Gondová: Personal communication.
3. Böyum, A.: Isolation of mononuclear cells and granulocytes from human blood. Isolation of mononuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g. Scand. J. clin. Invest.21, Suppl., 77?89 (1968).
4. Cantell, K., Hirvonen, S., Mogensen, K. E., Pyhälä, L.: Human leukocyte interferon: Production, purification, stability and animal experiments. In:Waymouth, C. (ed.), The production and use of interferon for the treatment and prevention of human virus infections. Rockville, Maryland,In vitro, Tissue Culture Association, 35?38 (1974).
5. Fantes, K. H.: Partial purification, concentration and properties of human leukocyte interferon. In: L'interféron, Coll. l'Inst. Nat. Santé & Rech. Med., Paris6, 181?186 (1970).